Fundz

Clover Biopharmaceuticals, Ltd. reported raising $38.1 Million in an initial SEC Form D filing

PUBLIC · CBPHFApr 28, 2021

Amount Raised

$38.1 Million

$38.1 Million sold, per SEC Form D (first sale Apr 28, 2021)

Round Type

Venture

ChinaBiotechnology

Who to call at Clover Biopharmaceuticals, Ltd., and when

A new round usually means Clover Biopharmaceuticals, Ltd. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Clover Biopharmaceuticals, Ltd. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Clover Biopharmaceuticals, Ltd., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Clover Biopharmaceuticals, Ltd.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Clover Biopharmaceuticals, Ltd.

Location

B5-19,Bldg 1,High-tech Incubation Park

China

About

Founded in 2007, we are a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world. With integrated research and development, manufacturing, and commercial capabilities as well as strong partnerships with organizations globally, we have developed a diverse pipeline of candidates that have the potential to meaningfully reduce the burden of vaccine-preventable diseases—and to make more diseases preventable. As we focus on delivering vaccines for a healthier world, we remain steadfast in our dedication to both scientific innovation and equitable access. Read our Community Guidelines: https://www.cloverbiopharma.com/community-guidelines.html

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Clover Biopharmaceuticals, Ltd. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPeng L., Executive Officer, Director, Promoter hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Clover Biopharmaceuticals, Ltd.'s next move

See what Strategic adds

Clover Biopharmaceuticals, Ltd. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.